Test Albuvirtide in Experienced Patients
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Dong Xie
Frontier Biotechnologies Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- 302 Hospital People'S Liberation Army of China
Beijing, Beijing Municipality, China
- Beijing Ditan Hospital, Capital Medical University
Beijing, Beijing Municipality, China
- Beijing Youan Hospital, Capital Medical University
Beijing, Beijing Municipality, China
- Guangzhou Eighth People'S Hospital
Guangzhou, Guangdong, China
- the Third People'S Hospital of Shenzhen
Shenzhen, Guangdong, China
- Henan Infectious Disease Hospital
Zhengzhou, Henan, China
- the First Hospital of Changsha
Changsha, Hunan, China
- the Second Xiangya Hospital of Central South University
Changsha, Hunan, China
- Shanghai Public Health Clinical Center
Shanghai, Shanghai Municipality, China
- Tangdu Hospital, Fourth Military Medical University
Xi’an, Shanxi, China
- Affiliated Hangzhou Xixi Hospital,zhejiang University School of Medicine
Hangzhou, Zhejiang, China
- the First Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Feb 2014
- Primary completion
- 2 Apr 2018
- Completion
- 2 Apr 2018
- Last update posted
- 6 Oct 2021
- Registered enrollment
- 418
- Registry id
- NCT02369965
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.